Jesse R Cloutier, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Suite 2100, Ellsworth, ME 04605 Phone: 207-664-5770 Fax: 207-664-5777 |
Miranda Chadbourne, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5770 |
James G Grossman, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 32 Resort Way, Ellsworth, ME 04605 Phone: 207-664-5480 Fax: 207-664-5490 |
Katharine Sherrill, PAC Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5340 Fax: 207-664-5338 |
Ms. Jane Reinoso, PA-C Physician Assistant - Medical Medicare: Medicare Enrolled Practice Location: 235 High St, Ellsworth, ME 04605 Phone: 207-412-5200 |
Thomas Macdonald, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5340 Fax: 207-664-5338 |
Alyssa Joy Diver, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 235 High St, Ellsworth, ME 04605 Phone: 207-412-5200 |
Brynia Marie Westra, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 50 Union St Ste 2300, Ellsworth, ME 04605 Phone: 207-664-5642 Fax: 207-664-5664 |
Mr. Craig A Hardy, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-7780 Fax: 207-664-7721 |
Hunt Gressitt, PA Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Maine Coast Memorial Hospital, Ellsworth, ME 04605 Phone: 207-664-5340 Fax: 207-664-5338 |
Mr. Dana L Green, PAC Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 50 Union St, Ellsworth Internal Medicine, Ellsworth, ME 04605 Phone: 207-664-7780 Fax: 207-664-7721 |
Everett Steinbarger, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 50 Union Street, Suite 2200, Ellsworth, ME 04605 Phone: 207-664-5858 Fax: 207-664-5860 |
Jeffrey Allen Davis, PAC Physician Assistant - Medical Medicare: Not Enrolled in Medicare Practice Location: 226 High St, Ellsworth, ME 04605 Phone: 207-667-4655 |
Lisa M Allen, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 32 Resort Way, Maine Coast Pediatrics, Ellsworth, ME 04605 Phone: 207-664-7744 Fax: 207-664-7724 |
Mr. Bradley Kent Lindstrom Jr., PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5340 Fax: 207-664-5338 |
Meaghan Meacham, PA-C Physician Assistant - Medical Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-400-6596 |
Christine Lee Sullivan, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 50 Union St., Suite 3500, Ellsworth, ME 04605 Phone: 207-664-5672 Fax: 207-664-5963 |
Christopher J Ward, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 235 High St, Ellsworth, ME 04605 Phone: 207-412-5200 Fax: 207-412-5201 |
Hilary Heron Hudson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 50 Union St, Ellsworth, ME 04605 Phone: 207-664-5770 Fax: 207-664-5777 |
News Archive
Rexahn Pharmaceuticals, Inc., a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the European Patent Office has granted European patent No. 1819698 to Rexahn for its novel anti-cancer quinoxalinyl-piperazine compounds.
A case study from Intel and UCSD highlights the transformative collaboration between the school's bioengineering department and the IntelĀ® Internet of Things (IoT).
Medulloblastoma is the most common type of solid brain tumor in children. Current treatments offer limited success and may leave patients with severe neurological side effects, including psychiatric disorders, growth retardation and cognitive impairment.
Alnylam Pharmaceuticals, Inc. has announced that it has filed a Clinical Trial Application (CTA) with the U.K. Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a Phase 1/2 clinical trial with ALN-AAT, a subcutaneously administered investigational RNAi therapeutic targeting alpha-1 antitrypsin (AAT) for the treatment of AAT deficiency-associated liver disease (alpha-1 liver disease).
› Verified 9 days ago